4//SEC Filing
Cooper Laurence James Neil 4
Accession 0001209191-20-005780
CIK 0001107421other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:45 PM ET
Size
7.3 KB
Accession
0001209191-20-005780
Insider Transaction Report
Form 4
Cooper Laurence James Neil
Chief Executive Officer
Transactions
- Award
Common Stock
2020-01-29+171,700→ 1,904,973 total - Award
Employee Stock Option (right to buy)
2020-01-29+264,200→ 264,200 totalExercise: $4.21Exp: 2030-01-29→ Common Stock (264,200 underlying)
Footnotes (2)
- [F1]57,234 shares shall vest on 12/31/2020 and 57,233 shares shall vest on each of 12/31/2021 and 12/31/2022.
- [F2]1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2019.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001641506
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:45 PM ET
- Size
- 7.3 KB